Write For Us

Pfizer Applies For emergency Use Of Covid Vaccine Amid Testing Bottleneck: CNBC After Hours

Video Player is loading.
Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
Sponsored Post Vitamin D2 Canada Persia
186 Views
Published
CNBC.com's MacKenzie Sigalos has the day's top business news headlines. Pfizer submitted its Covid-19 vaccine to the FDA for emergency authorization today, kicking off the first step of the approval and deployment process. But CNBC's Bertha Coombs explains how, at the same time, the combination of rising infection and Thanksgiving travel prep is putting a strain on some clinics that offer tests for the virus. Plus, the "After Hours" team dives into the rave reviews for Apple's new M1 chips.

00:00 -- Intro
0:40 -- Stocks close the week mixed
2:26 -- Covid-19 testing bottlenecks
4:13 -- CNBC Soundcheck
5:45 -- Apple's M1 Debut
9:37 -- Numbers Round
Category
Tech
Tags
CNBC, business, news
Show more
Sign in or sign up to post comments.
Be the first to comment